Auvelity, a treatment for major depressive disorder, is currently available. The drug is a combination of dextromethorphan and bupropion [1].
How is Auvelity Administered?
Auvelity is taken orally [1]. It is typically prescribed as one tablet taken orally twice daily [2].
What is the Typical Course of Treatment with Auvelity?
The recommended starting dose for Auvelity is one tablet taken orally twice daily for three days. Following this, the dose is increased to two tablets taken orally twice daily [2].
Who Manufactures Auvelity?
Amylyx Pharmaceuticals is the manufacturer of Auvelity [1].
When Did Auvelity Become Available?
The U.S. Food and Drug Administration (FDA) approved Auvelity in August 2022 [1].
What Are the Potential Side Effects of Auvelity?
Common side effects reported with Auvelity include dizziness, nausea, dry mouth, insomnia, constipation, and decreased appetite [1]. Serious side effects can include an increased risk of suicidal thoughts and behaviors, particularly in children, adolescents, and young adults. It may also cause seizures, elevated blood pressure, and angle-closure glaucoma [2].
What are the Safety Precautions for Auvelity?
Patients taking Auvelity should be monitored for worsening depression or emergence of suicidal thoughts and behaviors. It is contraindicated in individuals with a history of seizure disorder, anorexia nervosa, or bulimia nervosa, or in those undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs. Caution is advised in patients with certain cardiovascular conditions. Auvelity can also interact with other medications, requiring dose adjustments or avoidance [2].
What is the Clinical Trial Data Supporting Auvelity's Efficacy?
The efficacy of Auvelity was evaluated in two randomized, double-blind, placebo-controlled trials. In these studies, patients treated with Auvelity demonstrated statistically significant reductions in depressive symptoms compared to placebo, as measured by the Montgomery-Åsberg Depression Rating Scale (MADRS) total score [1].
What is the Patent Status for Auvelity?
Information regarding Auvelity's patent status, including expiry dates and potential challenges, can be found on DrugPatentWatch.com [3].
How does Auvelity Compare to Other Treatments for Depression?
Auvelity offers a novel mechanism of action by targeting NMDA receptors and inhibiting norepinephrine and dopamine reuptake. This differs from traditional selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) [1].
What Research is Ongoing for Auvelity?
Ongoing research may explore Auvelity's use in other mood disorders or for different patient populations. Updates on clinical trials and research can often be found on pharmaceutical company websites and clinical trial registries [1].
What is the Cost of Auvelity?
The cost of Auvelity can vary depending on insurance coverage and pharmacy. Patients are encouraged to discuss pricing and potential financial assistance programs with their healthcare provider or pharmacist [1].
---
Sources:
[1] https://www.auvelity.com/
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216428s000lbl.pdf
[3] https://www.drugpatentwatch.com/